GENE ONLINE|News &
Opinion
Blog

Bayer
GeneOnline’s Top Mergers and Acquisitions of 2020
2020-12-30
WuXi Biologics Acquires Bayer’s Drug Manufacturing Facility in Wuppertal
2020-12-25
Bayer’s New Anti-Tumor Drug BAY 2416964 Receives Approval for Clinical Use in China
2020-12-23
Is Bayer’s Entry to the Gene Therapy Market Worth it’s Investment?
2020-10-27
Foundation Medicine’s CGP Test FDA Approved as Companion Diagnostic for Bayer’s Tumor Agnostic Therapy
2020-10-26
Bayer Expands its Metastatic Breast Cancer Treatment
2020-09-18
AI Drug Pioneer Recursion Pharma Raises $239 Million Led by Leaps By Bayer
2020-09-12
The Evolution of Lung Cancer Therapies at a Glance
2020-04-16
First AI-Designed Drug to Enter Phase I Clinical Trial
2020-02-05
Weekly in Asia|Oct-2
2019-10-23
Weekly in Asia 2019|JULY-1
2019-07-19
Weekly in Asia 20190609-0615
2019-06-21
Expedited Approval of Vitrakvi® Marks Many Firsts in Cancer Therapy
2018-12-04
1 2
LATEST
Mechanisms of Allograft Rejection: Insights from Behind the Scenes
2024-04-25
ImmunityBio’s ANKTIVA® Granted FDA Approval: Breakthrough IL-15 Receptor Agonist First-in-Class for BCG-Unresponsive Non-Muscle Invasive Bladder Cancer
2024-04-24
Takeda, Astellas, and Sumitomo Mitsui Banking Declare Agreement For Early Drug Discovery Program Incubation in Joint Venture
2024-04-23
Ochre Bio Announces Partnership with Boehringer Ingelheim to Develop Novel Regenerative Treatments for Patients with Advanced Liver Disease
2024-04-22
Earth Day Awareness: Hospitals Embrace Sustainability Efforts
2024-04-22
WHO Raises Alarm: Bird Flu Threat to Humans an ‘Enormous Concern’
2024-04-19
The Legal Battlefield of Weight-Loss Drugs: Eli Lilly and Novo Nordisk on the Defensive
2024-04-18
EVENT
2024-04-27
2024 Biomedical Final Pitch Competition
Room DA1620, Dana Building, Dana-Farber Cancer Institute, 99 Jimmy Fund Way, Boston, MA 02115
Scroll to Top